AJOONI — Ajooni Biotech Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapNeutral

Annual income statement for Ajooni Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	510	740	745	801	1,147
Cost of Revenue
Gross Profit	80.3	100	87.5	97.6	177
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	500	721	727	788	1,121
Operating Profit	10.7	19.7	17.6	13.6	25.9
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5.04	14.6	15.8	30	43.3
Provision for Income Taxes
Net Income After Taxes	3.73	10.5	11.2	21.6	33.7
Net Income Before Extraordinary Items
Net Income	3.73	10.5	11.2	21.6	33.7
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3.73	10.5	11.2	21.6	33.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.058	0.157	0.113	0.22	0.2